-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, N0Yf6B5X9dfv6myYWKrrx/q3rtxS/UC7zkcSV3ytriBAkqXQVqm24EXVZXYk+4gt 7IJgFI+i0w6/tNrEPK8mYw== 0001056868-02-000010.txt : 20020710 0001056868-02-000010.hdr.sgml : 20020710 20020710144544 ACCESSION NUMBER: 0001056868-02-000010 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020710 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NEOTHERAPEUTICS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-49329 FILM NUMBER: 02699845 BUSINESS ADDRESS: STREET 1: 157 TECHNOLOGY DR STREET 2: STE J-821 CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9497886700 MAIL ADDRESS: STREET 1: 157 TECHNOLOGY DR STREET 2: STE J-821 CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SUMMIT CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001056868 IRS NUMBER: 911723315 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 601 UNION STREET STREET 2: SUITE 3900 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 2064476200 MAIL ADDRESS: STREET 1: 601 UNION STREET STREET 2: SUITE 3900 CITY: SEATTLE STATE: WA ZIP: 98101 SC 13G/A 1 neot13ga2.txt AMENDMENT 2 - BELOW 5% UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2) Neotherapeutics, Inc. (Name of issuer) Common Stock (Title of Class of Securities) 640656104 (Cusip Number) June 30, 2002 (Date of the Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: X Rule 13d-1(b) X Rule 13d-1(c) Rule 13d-1(d) CUSIP No. 640656104 ____________________________________________________________________ 1. Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) SUMMIT CAPITAL MANAGEMENT, LLC (#91-1723315) 2. Check the Appropriate Box if a Member of a Group (a) (b) 3. SEC Use Only ____________________________________________________ 4. Citizenship or Place of Organization - WASHINGTON STATE Number of 5. Sole Voting Power 0. Shares Beneficially 6. Shared Voting Power 361,468. Owned by Each Reporting 7. Sole Dispositive Power 0. Person With: 8. Shared Dispositive Power 361,468. 9. Aggregate Amount Beneficially Owned by Each Reporting Person 361,468 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) _____________________________________________ 11. Percent of Class Represented by Amount in Row (9) 1.304% 12. Type of Reporting Person (See Instructions) IA Item 1. (a) Name of Issuer Neotherapeutics, Inc. (b) Address of Issuer's Principal Executive Offices 157 Technology Drive, Suite J-821 Irvine, CA 92618 Item 2. (a) Name of Person Filing (a) SUMMIT CAPITAL MANAGEMENT, LLC; (b) SUMMIT CAPITAL PARTNERS, LP and (c) JOHN C. RUDOLF, INDIVIDUAL. (b) Address of Principal Business Office or, if none, Residence 601 UNION STREET, SUITE 3900 SEATTLE, WA 98101 (c) Citizenship WASHINGTON STATE (d) Title of Class of Securities COMMON STOCK (e) CUSIP Number 640656104 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) X An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E). (f) An employee benefit plan or endowment fund in accordance with 240.13d- 1(b)(1)(ii)(F). (g) A parent holding company or control person in accordance with 240.13d- 1(b)(1)(ii)(G). (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). (j) Group, in accordance with 240.13d-1(b)(1)(ii)(J). Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 361,468. (b) Percentage of class: 1.304%. (c) Number of shares as to which person has: (i) Sole power to vote or direct the vote: __0__(c). (ii) Shared power to vote or direct the vote: __361,468__(a,c). (iii) Sole power to dispose or to direct the disposition of: __0__(c). (iv) Shared power to dispose or to direct the disposition of: 361,468(a,c). Instruction. For computations regarding securities which represent a right to acquire an underlying security see 240.13d-3(d)(1). Item 5. Ownership of Five Percent of Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. __X__. Item 6. Ownership of More than Five Percent on Behalf of Another Person. If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employees benefit plan, pension fund or endowment fund is not required. N/A Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. If a parent holding company has filed this schedule, pursuant to Rule 13d- 1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d- 1(d), attach an exhibit stating the identification of the relevant subsidiary. N/A Item 8. Identification and Classification of Members of the Group If a group has filed this schedule pursuant to 240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to 240.13d-1(c) or 240.13d-1(d), attach an exhibit stating the identity of each member of the group. N/A Item 9. Notice of Dissolution of Group Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transaction sin the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. N/A Item 10. Certification (a) The following certification shall be included if the statement is filed pursuant to 240.13d-1(b): By signing below I certify that to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the affect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. (b) The following certification shall be included if the statement is filed pursuant to 240.13d-1(c): By signing below I certify that to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. July 10, 2002 Date John C. Rudolf Signature John C. Rudolf, Individually and as President of Summit Capital Mangagement, LLC on its own behalf and as General Partner for Summit Capital Partners, LP. Name/Title The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7 for other parties for whom copies are to be sent. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001). CUSIP No. 640656104 1. Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) SUMMIT CAPITAL PARTNERS, LP (#13-3198243) 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) _______________________________________________________________ (b) _______________________________________________________________ 3. SEC Use Only _______________________________________________________ 4. Citizenship or Place of Organization - WASHINGTON STATE Number of 5. Sole Voting Power 0. Shares Beneficially 6. Shared Voting Power 0. Owned by Each Reporting 7. Sole Dispositive Power 0. Person With: 8. Shared Dispositive Power 0. 9. Aggregate Amount Beneficially Owned by Each Reporting Person 325,868 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) _________________________________________________ 11. Percent of Class Represented by Amount in Row (9) 1.176% 12. Type of Reporting Person (See Instructions) PN CUSIP No. 640656104 1. Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) JOHN C. RUDOLF 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) _______________________________________________________________ (b) _______________________________________________________________ 3. SEC Use Only _______________________________________________________ 4. Citizenship or Place of Organization - WASHINGTON STATE Number of 5. Sole Voting Power 0. Shares Beneficially 6. Shared Voting Power 361,468. Owned by Each Reporting 7. Sole Dispositive Power 0. Person With: 8. Shared Dispositive Power 361,468. 9. Aggregate Amount Beneficially Owned by Each Reporting Person 361.468. 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) _________________________________________________ 11. Percent of Class Represented by Amount in Row (9) 1.304% 12. Type of Reporting Person (See Instructions) IN JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)1 This agreement is made pursuant to Rule 13d-1(k)1 under the Securities and Exchange Act of 1934 (the "Act") by and among the parties listed below, each referred to herein as a "Joint Filer". The Joint Filers agree that a statement of beneficial ownership as required by Section 13(d) of the Act and the Rules thereunder may be filed on each of their behalf on Schedule 13D or Schedule 13G, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers state that they each satisfy the requirements for making a joint filing under Rule 13d-1. Dated: July 10, 2002 John C. Rudolf, President Summit Capital Management, LLC John C. Rudolf, Individual John C. Rudolf, Managing Member Summit Capital Management, LLC, the General Partner of Summit Capital Partners, LP -----END PRIVACY-ENHANCED MESSAGE-----